Section Arrow
TECX.NASDAQ
- Tectonic Therapeutic Inc.
Quotes are at least 15-min delayed:2026/11/04 14:31 EST
Regular Hours
Last
 20.09
+1.11 (+5.85%)
Day High 
20.565 
Prev. Close
18.98 
1-M High
23.61 
Volume 
118.39K 
Bid
20.03
Ask
20.21
Day Low
19.33 
Open
19.995 
1-M Low
18.535 
Market Cap 
371.05M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 20.21 
20-SMA 21.02 
50-SMA 25.29 
52-W High 39.5278 
52-W Low 16.77 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-4.57/-5.35
Enterprise Value
371.09M
Balance Sheet
Book Value Per Share
11.45
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
0
Operating Revenue Per Share
--
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
CRISCuris Inc.1.2301+0.5162+72.31%0.2PE
KPTIKaryopharm Therapeutics Inc.0.0852-0.0031-3.51%-- 
GERNGeron Corp1.035+0.105+11.29%-- 
INOInovio Pharmaceuticals1.655-0.005-0.30%-- 
NRIXNurix Therapeutics16.31-9.51-36.83%10.63PE
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. The company focuses on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.